References

1. Lever, M. and S. Slow, The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem, 2010. 43 (9): p. 732-44.
2. Craig, S.A.S., Betaine in human nutrition. 2004.
3. Zhao, G., et al., Betaine in Inflammation: Mechanistic Aspects and Applications. Front Immunol, 2018. 9 : p. 1070.
4. Arumugam, M.K., et al.,Beneficial Effects of Betaine: A Comprehensive Review. Biology (Basel), 2021. 10 (6).
5. Kennedy, D.J., et al.,Substrate specificity and functional characterisation of the H+/amino acid transporter rat PAT2 (Slc36a2). Br J Pharmacol, 2005.144 (1): p. 28-41.
6. Thwaites, D.T. and C.M. Anderson,The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. Br J Pharmacol, 2011.164 (7): p. 1802-16.
7. Knight, L.S., et al., Betaine in the Brain: Characterization of Betaine Uptake, its Influence on Other Osmolytes and its Potential Role in Neuroprotection from Osmotic Stress. Neurochem Res, 2017. 42 (12): p. 3490-3503.
8. Slow, S., et al., Plasma Dependent and Independent Accumulation of Betaine in Male and Female Rat Tissues. 2009
9. Kharbanda, K.K., et al.,Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J Hepatol, 2007. 46 (2): p. 314-21.
10. Teng, Y.W., et al., Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue. J Biol Chem, 2012.287 (20): p. 16187-98.
11. Ommati, M.M. and R. Heidari,Betaine, heavy metal protection, oxidative stress, and the liver , in Toxicology . 2021. p. 387-395.
12. Ismaeel, A., Effects of betaine supplementation on muscle strength and power: A systematic review. 2017.
13. Cholewa, J.M., et al., The effects of chronic betaine supplementation on body composition and performance in collegiate females: a double-blind, randomized, placebo controlled trial. J Int Soc Sports Nutr, 2018. 15 (1): p. 37.
14. Willingham, B.D., T.J. Ragland, and M.J. Ormsbee, Betaine Supplementation May Improve Heat Tolerance: Potential Mechanisms in Humans. Nutrients, 2020.12 (10).
15. Kumar, T., G.S. Sharma, and L.R. Singh, Homocystinuria: Therapeutic approach. Clin Chim Acta, 2016. 458 : p. 55-62.
16. Lawson-Yuen, A. and H.L. Levy,The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab, 2006. 88 (3): p. 201-7.
17. Cholewa, J.M., L. Guimaraes-Ferreira, and N.E. Zanchi, Effects of betaine on performance and body composition: a review of recent findings and potential mechanisms. Amino Acids, 2014. 46 (8): p. 1785-93.
18. Forlani, G., et al., Three kinds of currents in the canine betaine-GABA transporter BGT-1 expressed in Xenopus laevis oocytes. 2001.
19. Kempson, S.A., Y. Zhou, and N.C. Danbolt, The betaine/GABA transporter and betaine: roles in brain, kidney, and liver. Front Physiol, 2014. 5 : p. 159.
20. Schwahn, B.C., et al.,Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br J Clin Pharmacol, 2003. 55 (1): p. 6-13.
21. Atkinson, W., et al.,Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects. 2008.
22. Awwad, H.M., et al.,Measurement of concentrations of whole blood levels of choline, betaine, and dimethylglycine and their relations to plasma levels. J Chromatogr B Analyt Technol Biomed Life Sci, 2014. 957 : p. 41-5.
23. Kunisawa, K., et al.,Betaine attenuates memory impairment after water-immersion restraint stress and is regulated by the GABAergic neuronal system in the hippocampus. Eur J Pharmacol, 2017. 796 : p. 122-130.
24. Ghatak, S., et al., Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases. Annu Rev Pharmacol Toxicol, 2021. 61 : p. 701-721.
25. Zhang, W., et al., The Role of the GABAergic System in Diseases of the Central Nervous System.Neuroscience, 2021. 470 : p. 88-99.
26. Latka, K., J. Jonczyk, and M. Bajda, Structure modeling of gamma-aminobutyric acid transporters - Molecular basics of ligand selectivity. Int J Biol Macromol, 2020.
27. Zafar, S. and I. Jabeen,Structure, Function, and Modulation of gamma-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic Prospective. Front Chem, 2018. 6 : p. 397.
28. Schousboe, A., et al., Role of the betaine/GABA transporter (BGT-1/GAT2) for the control of epilepsy. Eur J Pharmacol, 2004. 500 (1-3): p. 281-7.
29. Smith, M.D., et al.,Inhibition of the betaine-GABA transporter (mGAT2/BGT-1) modulates spontaneous electrographic bursting in the medial entorhinal cortex (mEC). Epilepsy Res, 2008. 79 (1): p. 6-13.
30. Lehre, A.C., et al.,Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice. Epilepsy Res, 2011.95 (1-2): p. 70-81.
31. Malik, S., et al.,Biomarkers of Major Depressive Disorder: Knowing is Half the Battle. Clin Psychopharmacol Neurosci, 2021. 19 (1): p. 12-25.
32. Trousselard, M., et al., Is plasma GABA level a biomarker of Post-Traumatic Stress Disorder (PTSD) severity? A preliminary study. Psychiatry Res, 2016. 241 : p. 273-9.
33. Kirischuk, S., et al.,Astrocyte sodium signaling and the regulation of neurotransmission. Glia, 2016. 64 (10): p. 1655-66.
34. Lee, M., E.G. McGeer, and P.L. McGeer, Mechanisms of GABA release from human astrocytes. Glia, 2011. 59 (11): p. 1600-11.
35. Bouter, Y., et al., Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice. Cannabis Cannabinoid Res, 2020. 5 (1): p. 51-61.
36. Beery, A.K. and D. Kaufer,Stress, social behavior, and resilience: insights from rodents.Neurobiol Stress, 2015. 1 : p. 116-127.
37. Qu, Y., et al., Betaine supplementation is associated with the resilience in mice after chronic social defeat stress: a role of brain-gut-microbiota axis. J Affect Disord, 2020. 272 : p. 66-76.
38. Singh, S., et al., Current therapeutic strategy in Alzheimer’s disease. Eur Rev Med Pharmacol Sci., 2012.
39. Hooshmand, B., et al.,Homocysteine and holotranscobalamin and the risk of Alzheimer disease. 2010.
40. Chai, G.S., et al., Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. J Neurochem, 2013. 124 (3): p. 388-96.
41. Liu, X.P., et al., Betaine suppressed Abeta generation by altering amyloid precursor protein processing. Neurol Sci, 2014. 35 (7): p. 1009-13.
42. Sun, J., et al.,Association between malnutrition and hyperhomocysteine in Alzheimer’s disease patients and diet intervention of betaine. J Clin Lab Anal, 2017. 31 (5).
43. Nie, C., et al., Betaine reverses the memory impairments in a chronic cerebral hypoperfusion rat model. Neurosci Lett, 2016. 615 : p. 9-14.
44. Shulman, L., Levodopa Toxicity in Parkinson Disease: Reality or Myth? 2000.
45. Muller, T., et al.,Elevation of total homocysteine levels in patients with Parkinson’s disease treated with duodenal levodopa/carbidopa gel. J Neural Transm (Vienna), 2011. 118 (9): p. 1329-33.
46. Imamura, K., et al.,Homocysteine is toxic for dopaminergic neurons in primary mesencephalic culture. 2007.
47. Chandra, G., et al., Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats. Brain Res, 2006. 1075 (1): p. 81-92.
48. Muller, T., et al.,Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson’s disease. J Neural Transm (Vienna), 2006.113 (10): p. 1441-8.
49. Alirezaei, M., et al.,Beneficial antioxidant properties of betaine against oxidative stress mediated by levodopa/benserazide in the brain of rats. J Physiol Sci, 2015. 65 (3): p. 243-52.
50. Amiraslani, B., et al.,Recognition of betaine as an inhibitor of lipopolysaccharide-induced nitric oxide production in activated microglial cells. Iran Biomed J, 2012. 16 (2): p. 84-9.
51. Im, A.R., et al., Betaine protects against rotenone-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol, 2013. 33 (5): p. 625-35.
52. Li, Q., et al., Betaine protects rats against ischemia/reperfusion injury-induced brain damage.J Neurophysiol, 2022. 127 (2): p. 444-451.
53. Kraepelin, E., Dementia praecox and paraphrenia . 1919: Livingstone.
54. Suzuki-Abe, H., et al.,Metabolomic and pharmacologic analyses of brain substances associated with sleep pressure in mice. Neurosci Res, 2022.177 : p. 16-24.
55. Yoshihara, S., et al.,Betaine ameliorates schizophrenic traits by functionally compensating for KIF3-based CRMP2 transport. Cell Rep, 2021.35 (2): p. 108971.
56. Ohnishi, T., et al.,Investigation of betaine as a novel psychotherapeutic for schizophrenia. EBioMedicine, 2019. 45 : p. 432-446.
57. Ibi, D., et al.,Involvement of GAT2/BGT-1 in the preventive effects of betaine on cognitive impairment and brain oxidative stress in amyloid beta peptide-injected mice. Eur J Pharmacol, 2019. 842 : p. 57-63.
58. Wu, B.T., et al., Early second trimester maternal plasma choline and betaine are related to measures of early cognitive development in term infants. PLoS One, 2012. 7 (8): p. e43448.
59. Caro, A.A. and A.I. Cederbaum,Antioxidant properties of S-adenosyl-L-methionine in Fe(2+)-initiated oxidations. Free Radic Biol Med, 2004.36 (10): p. 1303-16.
60. Schwab, U., et al., Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. 2002.
61. Millard, H.R., et al.,Dietary choline and betaine; associations with subclinical markers of cardiovascular disease risk and incidence of CVD, coronary heart disease and stroke: the Jackson Heart Study. Eur J Nutr, 2018.57 (1): p. 51-60.
62. Yang, Y., et al., High Betaine and Dynamic Increase of Betaine Levels Are Both Associated With Poor Prognosis of Patients With Pulmonary Hypertension. Front Cardiovasc Med, 2022. 9 : p. 852009.
63. Mukherjee, S., Betaine and nonalcoholic steatohepatitis: back to the future? World J Gastroenterol, 2011. 17 (32): p. 3663-4.
64. Van Every, D.W., et al.,Betaine Supplementation: A Critical Review of Its Efficacy for Improving Muscle Strength, Power, and Body Composition. Strength & Conditioning Journal, 2021. 43 (4): p. 53-61.